{"database": "lobbying", "table": "lobbying_activities", "rows": [[2032727, "cb735764-282e-4ca1-8cf8-806cccd534d7", "Q3", "BUCHANAN INGERSOLL & ROONEY PC", 55291, "60 DEGREES PHARMACEUTICALS", 2017, "third_quarter", "PHA", "Government relations services relating to priority review voucher within the user fee reauthorization legislation (S.934/HR2430).", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2017-10-19T10:55:47.023000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2032727"], "units": {}, "query_ms": 0.3644289681687951, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}